KeyBank National Association
CGON icon

KeyBank National Association’s CG Oncology CGON Stock Holding History

KeyBank National Association’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Buy
+3,301
New +$187K ﹤0.01% 1147

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KeyBank National Association's CGON Position: Q1 2026 in Review

KeyBank National Association opened a new position in CG Oncology (CGON) in Q1 2026: 3,301 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #1147 among its holdings.

233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • KeyBank National Association held 3,301 shares of CG Oncology worth $223K as of Q1 2026.
  • CG Oncology was a new KeyBank National Association position in Q1 2026.
  • CG Oncology made up ﹤0.01% of KeyBank National Association's portfolio in Q1 2026, its #1147 holding.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on KeyBank National Association's 13F filing for Q1 2026, filed 24 Apr 2026.